STOCK TITAN

TrueBlue (TBI) SEC Filings, Feb 24, 2026

TBI NYSE

TrueBlue, Inc. filings document the public-company disclosures of a specialized workforce solutions provider whose common stock trades on the New York Stock Exchange under TBI. Its Form 8-K reports cover quarterly results, Regulation FD materials, material agreements, financing arrangements, executive appointments and governance-related communications.

TrueBlue proxy and related filings describe annual meeting matters, board governance, compensation and shareholder voting procedures. Recent filings also document amendments to the company’s credit agreement, stockholder rights arrangements, the expiration and withdrawal from listing of preferred stock purchase rights, and solicitation materials connected to shareholder engagement and board matters.

Rhea-AI Summary

TrueBlue EVP and CFO Carl Schweihs reported mixed equity transactions. On February 20, he acquired 112,507 shares of TrueBlue common stock through a grant of restricted stock units that will vest in equal installments over three years. On February 21, he disposed of 5,974 shares in a tax-withholding transaction related to equity compensation. After these moves, he directly owned 276,569 common shares, including approximately 9,560 shares acquired through the company’s employee stock purchase plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.01%
Tags
insider
-
Rhea-AI Summary

TrueBlue, Inc. EVP and Chief Legal Officer Garrett Ferencz reported both an equity award and a related tax share disposition. On February 20, 2026, he received a grant of 91,092 restricted stock units, which will convert into the same number of common shares in the future and vest in three equal annual installments.

On February 21, 2026, 4,468 common shares were disposed of at $3.71 per share to cover tax obligations, a non-open-market transaction. After these updates and corrections for previously omitted employee stock purchase plan shares, his reported direct beneficial ownership reflects these changes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.01%
Tags
insider
-
Rhea-AI Summary

TrueBlue, Inc. director Paul G. Reitz reported an equity award rather than an open-market trade. He acquired 27,566 shares of Common Stock through a grant of restricted stock units that will settle into shares on a one-for-one basis in the future.

These restricted stock units vest in full one year from the grant date, tying his compensation to the company’s performance over that period. After this grant, his reported direct holdings increased to 58,312 shares of Common Stock, aligning his interests more closely with other shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.01%
Tags
insider
Rhea-AI Summary

TrueBlue, Inc. director Jeffrey B. Sakaguchi reported an equity award on Common Stock. He acquired 35,733 restricted stock units at a stated price of $0.00 per share, increasing his directly held stake to 124,443 shares after the transaction. The restricted stock units will be settled one-for-one in Common Stock and vest in full one year from the grant date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.01%
Tags
insider
-
Rhea-AI Summary

TrueBlue, Inc. director William J. Seward reported an equity compensation grant of 27,566 shares of Common Stock on February 20, 2026. The filing describes this as an acquisition through a grant or award, with no cash price per share reported.

A footnote explains the award is in the form of restricted stock units that will settle into Common Stock on a one-for-one basis in the future. These restricted stock units are scheduled to vest in full one year from the grant date, and Seward’s directly held stake after the grant is 27,566 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.01%
Tags
insider
-
Rhea-AI Summary

TrueBlue, Inc. director William C. Goings reported an equity award of 29,607 shares of Common Stock in the form of restricted stock units. These units vest in full one year from the grant date and will be settled one-for-one in shares after he leaves the Board.

Following this award, his reported holdings total 85,000 shares, which the footnotes state are deferred under the company’s Equity Retainer and Deferred Compensation Plan for Non-Employee Directors. The award has no cash exercise price and represents additional long-term, stock-based compensation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.01%
Tags
insider
Rhea-AI Summary

Greenblatt William reported acquisition or exercise transactions in this Form 4 filing.

TrueBlue, Inc. director William Greenblatt reported an equity award of 27,566 shares of common stock, received as a grant of restricted stock units at no cash cost. The units will be settled one-for-one in common shares and vest in full one year after the grant date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.01%
Tags
insider
-
Rhea-AI Summary

TrueBlue, Inc. director Sonita Lontoh acquired an equity award through a Form 4 filing. She received 27,566 restricted stock units of TrueBlue common stock as a grant, with no cash paid per share. These units will be settled one-for-one in common shares and vest in full one year from the grant date. After this award, her reported direct holdings total 74,919 shares of common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.01%
Tags
insider
-
Rhea-AI Summary

TrueBlue, Inc. director Kristi A. Savacool reported an equity award of 27,566 shares of Common Stock, received as a grant of restricted stock units at no cash cost to her. These units will convert into shares on a one-for-one basis.

The restricted stock units vest in full one year from the grant date, with delivery of the vested shares scheduled 90 days after her separation from service on the Board. Following this award, she reports direct beneficial ownership of 89,536 shares, including 82,940 shares deferred under the company’s director compensation plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.01%
Tags
insider
Rhea-AI Summary

Kreidler Robert C. reported acquisition or exercise transactions in this Form 4 filing.

TrueBlue, Inc. director Robert C. Kreidler reported an equity award of 27,566 shares of common stock in the form of restricted stock units. These units will vest in full one year from the grant date and will be settled on a one-for-one basis in common shares.

Delivery of the vested shares to Kreidler will occur 90 days after his separation from service on the Board of Directors. Following this award, his directly held and deferred holdings total 85,381 shares, including 71,664 shares deferred under the company’s Equity Retainer and Deferred Compensation Plan for Non-Employee Directors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.01%
Tags
insider

FAQ

How many TrueBlue (TBI) SEC filings are available on StockTitan?

StockTitan tracks 87 SEC filings for TrueBlue (TBI), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for TrueBlue (TBI)?

The most recent SEC filing for TrueBlue (TBI) was filed on February 24, 2026.